Hernandez, Maria V.
,
Sanchez-Piedra, Carlos
Garcia-Magallon, Blanca
Cuende, Eduardo
Manero, Javier
Campos-Fernandez, Cristina
Martin-Domenech, Raquel
del Pino-Montes, Javier
Manrique, Sara
Castro-Villegas, Maria C.
Ruiz-Montesinos, Dolores
Sanchez-Alonso, Fernando
Diaz-Gonzalez, Federico
Cea-Calvo, Luis
Gómez-Reino, Juan J.
Funding for this research was provided by:
Merck Sharp and Dohme Spain
Article History
Received: 1 August 2018
Accepted: 13 October 2018
First Online: 24 October 2018
Compliance with ethical standards
:
: L Cea-Calvo is an employee of Merck Sharp & Dohme, Spain. The other authors declare no conflict of interest in relation to this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients signed informed consent to be included in the BIOBADASER registry. Informed consent included consent for subsequent analysis, such as in the present analysis. Patients’ information was managed as anonymized aggregated data and, as approved by the Clinical Research Committee, specific informed consent for this analysis was not required.